SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (14169)2/3/1998 7:13:00 PM
From: tonyt  Respond to of 32384
 
> for all the buy recs that the "mightier than thou" brokerage firms have on lgnd.

After this heavy volume ('selling') is over, watch out for the downgrades.



To: Hippieslayer who wrote (14169)2/4/1998 12:35:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Fugazi, LGND has been public since 1992 (as LGNDA) and they have had coverage since then. I can't recall any downgrades in over 5 years. I expect new coverage (BUYS or STRONG BUYS) to begin shortly. Biotechs should start to get some respect from the merger mania and LGND's price is extremely attractive, which has historically been the time to start coverage (LGND was about 6 when Bear Stearns began in 1995).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News